版本:
中国

BRIEF-Intellia Therapeutics reports qtrly loss per share of $0.36

May 2 Intellia Therapeutics Inc :

* Intellia Therapeutics announces first quarter 2017 financial results

* Q1 collaboration revenue $6.2 million

* Qtrly loss per share $0.36

* Cash and cash equivalents at march 31, 2017, were $258 million, compared to $64 million for same quarter in 2016

* During 2017, co expects expenses to continue to increase compared to prior periods Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐